Quality of lifeMultimorbidity: Prevalence, Effect on Quality of Life and Daily Functioning, and Variation of This Effect When one Condition Is a Rheumatic Disease
Section snippets
Study Design
The EPISER study was a health survey conducted by the Spanish Society of Rheumatology in 1999 to 2000 to assess the prevalence and burden of musculoskeletal diseases in the general population of Spain. This study has been previously described in detail (22).
Sample and Data Collection
A random sample of subjects older than 20 years was drawn in 3 stages. First, the country, which is composed of 19 autonomous communities, was divided into 8 strata, according to geographical and cultural proximity, each of which was roughly
Results
A random sample of 2998 subjects was selected from an eligible population of 972,545. The final sample sized comprised 2192 subjects who completed the interview, giving a response rate of 73%. The estimated prevalence for the 9 groups of chronic diseases was as follows: rheumatic diseases, 23% (19-26); hypertension, 17% (15-19); hypercholesterolemia, 14% (10-17); digestive diseases, 10% (7-13); allergies, 8% (5-11); cardiac diseases, 6% (5-7); pulmonary diseases, 6% (5-7); diabetes, 5% (4-6);
Discussion
Our results highlight the importance of the co-occurrence of 2 or more chronic conditions in the same person (multimorbidity) as a major health problem in the general population. Multimorbidity is frequent and negatively affects HRQoL and daily functioning. We have also shown the additional negative effect of having a rheumatic disease as part of this multimorbidity.
Two major strengths of this study are the representativeness of the study sample, as previously shown (22), and the high response
Acknowledgments
EPISER was supported by a grant from the Fondo de Investigaciones de la Seguridad Social (FIS 99/0251) and sponsored by Merck Sharp and Dohme España. The authors appreciate the invaluable help of government personnel in the study cities and at the health centers that provided the time and space for the survey. Pharmaconsult (Madrid, Spain) was responsible for the study logistics.
References (43)
- et al.
Problems in determining occurrence rates of multimorbidity
J Clin Epidemiol
(2001) - et al.
Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases
J Clin Epidemiol
(1998) - et al.
Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10-year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly)
J Clin Epidemiol
(2001) - et al.
Comorbidity and breast cancer survival: a comparison between black and white women
Ann Epidemiol
(1996) - et al.
Chronic comorbidity and outcomes of hospital care: length of stay, mortality, and readmission at 30 and 365 days
J Clin Epidemiol
(1999) - et al.
Health-related quality of life in individuals with chronic obstructive pulmonary disease
Heart Lung
(2005) - et al.
Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA ProjectInternational Quality of Life Assessment
J Clin Epidemiol
(1998) - et al.
[Validity of the occupation as an indicator of social class, according to the British Registrar General classification]
Gac Sanit
(1997) - et al.
Self-reported thyroid disease and mental disorder prevalence in the general population
Gen Hosp Psychiatry
(2006) - et al.
Persons with chronic conditionsTheir prevalence and costs
JAMA
(1996)
Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) Project
Qual Life Res
Morbidity, comorbidity, and their association with disability among community-dwelling oldest-old in Israel
J Gerontol A Biol Sci Med Sci
Prevalence of multimorbidity among adults seen in family practice
Ann Fam Med
Partnership for solutionsChronic Conditions: Making the case for ongoing care. Robert Wood Johnson Foundation and John Hopkins University
The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacementComorbidity and outcomes after hip replacement
Med Care
Patient-related risk factors that predict poor outcome after total hip replacement
Health Serv Res
Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis
J Rheumatol
The cost of diabetes in the presence of comorbid conditions
Manag Care Interface
Health and disability costs of depressive illness in a major U.S. corporation
Am J Psychiatry
Multimorbidity and quality of life in primary care: a systematic review
Health Qual Life Outcomes
Quality of life in dementia: more than just cognitionAn analysis of associations with quality of life in dementia
J Neurol Neurosurg Psychiatry
Cited by (109)
The association between comorbidity and physical activity levels in people with osteoarthritis: Secondary analysis from two randomised controlled trials
2020, Osteoarthritis and Cartilage OpenMultimorbidity and quality of life: Systematic literature review and meta-analysis
2019, Ageing Research ReviewsCitation Excerpt :Heterogeneity was again very high I2 = 99.99% (Fig. 5). Fifteen studies (Cheng et al., 2003; Chin et al., 2016; Fortin et al., 2006; Garrido-Abejar et al., 2012; Hodek et al., 2009; Hu, 2007; Lim et al., 2012; Loza et al., 2009; Luo et al., 2015; Naveiro-Rilo et al., 2014; Prazeres and Santiago, 2016; Rillamas-Sun et al., 2016; Tyack et al., 2016; Williams and Egede, 2016; Xie et al., 2016) were included in the analysis of the physical component of the SF instrument, while 13 studies (Cheng et al., 2003; Fortin et al., 2006; Garrido-Abejar et al., 2012; Hodek et al., 2009; Hu, 2007; Lim et al., 2012; Loza et al., 2009; Luo et al., 2015; Naveiro-Rilo et al., 2014; Prazeres and Santiago, 2016; Tyack et al., 2016; Williams and Egede, 2016; Xie et al., 2016) were included in the mental component score analysis. Results showed that physical health deteriorates −3.27% (95%CI: −4.79%, −1.74%) with each added condition, while the mental health decline was less steep, −1.55% (95%CI: −2.97%, −0.13%).
Assessment of limitations in rheumatology. Tools most used in practice
2019, Revista Colombiana de Reumatologia